Inactive Instrument

Other languages Aastrom Biosciences Inc Nasdaq

Equities

US00253U3059

End-of-day quote Nasdaq Other stock markets
- ^USD	-

May. 08	Vericel Q1 Loss Narrows, Revenue Increases; 2024 Outlook Lifted -- Shares Rise Pre-Bell	MT
May. 08	Earnings Flash (VCEL) VERICEL CORPORATION Posts Q1 Revenue $51.3M, vs. Street Est of $49.1M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vericel Q1 Loss Narrows, Revenue Increases; 2024 Outlook Lifted -- Shares Rise Pre-Bell	May. 08
Vericel Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 08
Vericel Corporation Provides Earnings Guidance for the Year 2024	May. 08
Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing	Apr. 19
Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing	Mar. 15
Vericel Insider Sold Shares Worth $352,047, According to a Recent SEC Filing	Mar. 13
Vericel Insider Sold Shares Worth $367,853, According to a Recent SEC Filing	Mar. 11
Vericel Q4 EPS, Revenue Increase; Issues 2024 Outlook -- Shares Rise Pre-Bell	Feb. 29
Vericel Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29
Vericel Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29
Vericel Corporation Provides Earnings Guidance for the Fiscal Year 2024	Feb. 29
Vericel Insider Sold Shares Worth $1,677,200, According to a Recent SEC Filing	Feb. 16
Vericel Insider Sold Shares Worth $334,775, According to a Recent SEC Filing	Jan. 24
Vericel Insider Sold Shares Worth $1,280,375, According to a Recent SEC Filing	Jan. 19
Vericel Corporation Provides Earnings Guidance for the Year 2024	Jan. 10
Vericel Reports Q4 Preliminary Unaudited Revenue; Shares Rise	Jan. 09
Vericel Corporation Provides Earnings Guidance for the Fourth Quarter and Full-Year 2023	Jan. 09
Vericel Insider Sold Shares Worth $853,800, According to a Recent SEC Filing	Dec. 15
Vericel Insider Sold Shares Worth $832,909, According to a Recent SEC Filing	Dec. 08
Vericel Insider Sold Shares Worth $617,798, According to a Recent SEC Filing	Dec. 01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Aastrom Biosciences Inc Nasdaq

Equities

US00253U3059

Other languages

Filters